Cannabis investors might have to wait longer for legalization – The Average Joe
Business Economy Tech Subscribe About Us

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.

    Cannabis investors might have to wait longer for legalization


    February 2, 2022


    Patience is the name of the game for investors waiting for an all-clear from Uncle Sam on cannabis legalization. Cannabis stocks are down 60% since last February — while the S&P 500 is up nearly 15%.

    Hopes of legalization fell flat from Republican pushback and red tape. Could 2022 look different as support builds on both sides?

    What are the chances of a 2022 move?

    Over the years, the industry faced continued difficulties from a lack of White House support and access to banking services — with bills failing to pass the Senate. Despite legal issues, the sector is growing at a rapid pace — companies becoming stronger and more profitable.

    • The $23B US cannabis market is expected to double by 2025.
    • Trulieve (OTC:TCNNF) reported their 15th consecutive profitable quarter.
    • Green Thumb Industries Inc.’s (OTC:GTBIF) earnings more than doubled.

    Weed stocks are trading at such cheap valuations and with such solid financials and growth — they’re looking like both a growth and value stock.

    2022 legalization on the table? Insiders believe federal reform still seems unlikely before the US November midterm elections. But cannabis is definitely on the agenda — with cannabis legislation on the 2022 ballots of states like Florida, Idaho, Mississippi and Ohio.

    Big tech going green

    In a surprising turn of events, cannabis saw support from one big tech company. Last week, Amazon (NASDAQ:AMZN) came out in favor of the GOP bill to decriminalize marijuana — which has impacted its ability to hire amid a labor shortage:

    • Expunging some marijuana-related crimes would widen applicant pools.
    • Easing criteria for drug testing would improve employee retention.

    Amazon previously backed the industry in June when they endorsed the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act — sending cannabis stocks up.

    Investors: Cannabis for value investors?

    According to Aaron Edelheit of Mindset Capital, long-term investors looking for a good balance of growth, value and upside — should consider cannabis stocks. Many of these US cannabis stocks trade on over-the-counter exchanges — one of the few ways to trade them being the AdvisorShares Pure US Cannabis ETF (NYSE:MSOS).

    • AYR Wellness (OTC: AYRWF) — saw annual revenue growth of 111% to 96.2M, with a target of $800M in 2022.
    • Verano (OTC: VRNOF) — produced over $360M this year and is estimated to produce $600M in 2022.

    Federal legalization would unleash strong demand towards these cannabis stocks — which have been unavailable to US investors. But be warned, changes of legalization in 2022 are looking slim.

    Trending Posts